Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-0425PMID 16540663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL

  2004cited by this paper
• Akt Inhibits Apoptosis Downstream of BID Cleavage via a Glucose-Dependent Mechanism Involving Mitochondrial Hexokinases

  2004cited by this paper
• p53 Activation Domain 1 Is Essential for PUMA Upregulation and p53-Mediated Neuronal Cell Death

  2004cited by this paper
• Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage.

  2004cited by this paper
• Differentiation-dependent Sensitivity to Apoptogenic Factors in PC12 Cells*

  2004cited by this paper
• Sensitization of cells to TRAIL-induced apoptosis by decoy receptor 3.

  2004influential reference
• Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis

  2004influential reference
• Bax Mediates the Apoptosis-Sensitizing Effect of Maspin

  2004influential reference
• In Vivo Mitochondrial p53 Translocation Triggers a Rapid First Wave of Cell Death in Response to DNA Damage That Can Precede p53 Target Gene Activation

  2004cited by this paper
• Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53.

  2004influential reference
• Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosis

  2004cited by this paper
• A novel site of AKT‐mediated phosphorylation in the human MDM2 onco‐protein

  2004cited by this paper
• PI3K/Akt signalling pathway and cancer.

  2004cited by this paper
• Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro

  2004cited by this paper
• The Pathophysiology of Mitochondrial Cell Death

  2004cited by this paper
• Nuclear Factor-κB Modulates the p53 Response in Neurons Exposed to DNA Damage

  2004cited by this paper
• Sensitization of Cells to TRAIL-induced Apoptosis by Decoy Receptor 3*

  2004cited by this paper
• Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300

  2003cited by this paper
• The MDM2-p53 interaction.

  2003cited by this paper
• AKT2 Inhibition of Cisplatin-induced JNK/p38 and Bax Activation by Phosphorylation of ASK1

  2003cited by this paper
• Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.

  2003cited by this paper
• PI3K/Akt and apoptosis: size matters

  2003cited by this paper
• A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors

  2003cited by this paper
• p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.

  2003influential reference
• p53 has a direct apoptogenic role at the mitochondria.

  2003influential reference
• Proteasome-mediated Degradation of Smac during Apoptosis: XIAP Promotes Smac Ubiquitination in Vitro *

  2002cited by this paper
• Cell death regulation by the mammalian IAP antagonist Diablo/Smac

  2002cited by this paper
• Regulation of the mitochondrial checkpoint in p53-mediated apoptosis confers resistance to cell death

  2002influential reference
• Live or let die: the cell's response to p53

  2002cited by this paper
• Mechanisms of caspase activation and inhibition during apoptosis.

  2002cited by this paper
• Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

  2002cited by this paper
• XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.

  2001cited by this paper
• A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

  2001cited by this paper
• HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

  2001cited by this paper
• A structural view of mitochondria-mediated apoptosis

  2001cited by this paper
• Hepatocyte Growth Factor/Scatter Factor Blocks the Mitochondrial Pathway of Apoptosis Signaling in Breast Cancer Cells*

  2001cited by this paper
• Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.

  2000influential reference
• Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins.

  2000cited by this paper
• Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.

  2000cited by this paper
• Death Signal-induced Localization of p53 Protein to Mitochondria

  2000cited by this paper
• Regulation of p53 Function and Stability by Phosphorylation

  1999cited by this paper
• Regulation of Mdm2-Directed Degradation by the C Terminus of p53

  1998cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked

  1997cited by this paper
• p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study.

  1997cited by this paper
• Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

  1995cited by this paper

• The flavonoid hyperoside attenuates the toxic effect of cisplatin on the human ovarian granulosa cells: in vitro model study

  2025cites this paper
• Statins as potential adjuvant therapy in lung cancer: a narrative review

  2023cites this paper
• Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment

  2023cites this paper
• The role of peptides in reversing chemoresistance of breast cancer: current facts and future prospects

  2023cites this paper
• PD-1/PD-L1 and DNA Damage Response in Cancer

  2023cites this paper
• Activation of PI3K/Akt pathway by G protein‐coupled receptor 37 promotes resistance to cisplatin‐induced apoptosis in non‐small cell lung cancer

  2023cites this paper
• Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes

  2022cites this paper
• Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers

  2022influential citation
• Melatonin Sensitizes OVCAR-3 Cells to Cisplatin through Suppression of PI3K/Akt Pathway.

  2022cites this paper
• Collagen XI Alpha 1 Chain, a Novel Therapeutic Target for Cancer Treatment

  2022cites this paper
• Treating non-small cell lung cancer by targeting the PI3K signaling pathway

  2022cites this paper
• Erlotinib or Gefitinib for the Treatment of Relapsed Platinum Pretreated NSCLC and Ovarian Cancer: a Systematic Review

  2022cites this paper
• Horizontal Transfer of miR-643 from Cisplatin-Resistant Cells Confers Chemoresistance to Recipient Drug-Sensitive Cells by Targeting APOL6

  2021cites this paper
• Integrated physiological, transcriptome and metabolome analyses of the hepatopancreas of the female swimming crab Portunus trituberculatus under ammonia exposure.

  2021cites this paper
• Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers

  2021cites this paper
• Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer

  2021cites this paper
• Melatonin Sensitize the Ovarian Cancer Cells to Cisplatin through suppression of PI3K/Akt pathway

  2021cites this paper
• Cisplatin Resistance in Ovarian Cancer: Classical Outlook and Newer Perspectives

  2021cites this paper
• Insights of Cisplatin Resistance in Cervical Cancer: A Decision Making for Cellular Survival

  2021cites this paper
• Nanoscale Metal-Organic Layers Detect Mitochondrial Dysregulation and Chemoresistance via Ratiometric Sensing of Glutathione and pH.

  2021cites this paper
• Drug resistance in gynecologic cancers: Findings and underlying mechanisms

  2021cites this paper
• LNX1 Contributes to Cell Cycle Progression and Cisplatin Resistance

  2021cites this paper
• Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells

  2021cites this paper
• Using intracellular metabolic profiling to identify novel biomarkers of cisplatin-induced acute kidney injury in NRK-52E cells

  2021cites this paper
• FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway

  2021cites this paper
• Integrated Analysis of Germ Cell Tumors.

  2021cites this paper
• Chemoresistance in uterine cancer: Mechanisms of resistance and current therapies

  2021cites this paper
• IGF-1R anti-idiotypic antibody antagonist exhibited anti-ovarian cancer bioactivity and reduced cisplatin resistance

  2021cites this paper
• MK2206 Enhances Cisplatin-Induced Cytotoxicity and Apoptosis in Testicular Cancer Through Akt Signaling Pathway Inhibition

  2020cites this paper
• MARK2 enhances cisplatin resistance via PI3K/AKT/NF-κB signaling pathway in osteosarcoma cells.

  2020cites this paper
• Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

  2020cites this paper
• Linc-ROR promotes arsenite-transformed keratinocyte proliferation by inhibiting P53 activity.

  2020cites this paper
• Cordyceps sinensis attenuates HBx‑induced cell apoptosis in HK‑2 cells through suppressing the PI3K/Akt pathway.

  2020cites this paper
• The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair

  2020cites this paper
• The AKT/GSK3β mediated Slug expression contributes to oxaliplatin resistance in 4 colorectal cancer via up-regulation of ERCC1.

  2020cites this paper
• The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance

  2019cites this paper
• Alpha7 nAChR Expression Is Correlated with Arthritis Development and Inhibited by Sinomenine in Adjuvant-Induced Arthritic Rats

  2019cites this paper
• Molecular and Cellular Basis of Chemoresistance in Ovarian Cancer

  2019cites this paper
• Crosstalk between Phosphoinositide 3‐kinase/Akt signaling pathway with DNA damage response and oxidative stress in cancer

  2019cites this paper
• CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis in ovarian cancer

  2019cites this paper
• GRK2 promotes growth of medulloblastoma cells and protects them from chemotherapy-induced apoptosis

  2019cites this paper
• Title MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway

  2019cites this paper
• p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling

  2019cites this paper
• Stretching magnitude–dependent inactivation of AKT by ROS led to enhanced p53 mitochondrial translocation and myoblast apoptosis

  2019cites this paper
• Scutellarin synergistically enhances cisplatin effect against ovarian cancer cells through enhancing the ability of cisplatin binding to DNA

  2019cites this paper
• Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy

  2019cites this paper
• Fidelity of a PDX-CR model for bladder cancer.

  2019cites this paper
• VX-680 induces p53-mediated apoptosis in human cholangiocarcinoma cells

  2018cites this paper
• Origins based clinical and molecular complexities of epithelial ovarian cancer.

  2018cites this paper
• TIMP-1 downregulation modulates miR-125a-5p expression and triggers the apoptotic pathway

  2018cites this paper
• Chemoresistance and targeting of growth factors/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer.

  2018cites this paper
• MiR-514 attenuates proliferation and increases chemoresistance by targeting ATP binding cassette subfamily in ovarian cancer

  2018cites this paper
• Tumor metabolism regulating chemosensitivity in ovarian cancer

  2018influential citation
• Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance

  2018cites this paper
• Mutational Analysis of Oncogenic AKT1 Gene Associated with Breast Cancer Risk in the High Altitude Ecuadorian Mestizo Population

  2018cites this paper
• Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts

  2017cites this paper
• Synuclein‐γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study

  2017cites this paper
• Incorporating prior information into differential network analysis using non‐paranormal graphical models

  2017cites this paper
• MK 2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway

  2017cites this paper
• The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer

  2017cites this paper
• Cisplatin Analogues with an Increased Interaction with DNA: Prospects for Therapy.

  2017cites this paper
• CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway

  2017cites this paper
• Overexpression of Activin Receptor-like Kinase 7 in Breast Cancer Cells Is Associated with Decreased Cell Growth and Adhesion.

  2017cites this paper
• miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10

  2017cites this paper
• Prodelphinidins isolated from Chinese bayberry leaves induces apoptosis via the p53-dependent signaling pathways in OVCAR-3 human ovarian cancer cells.

  2017cites this paper
• High BIM mRNA levels are associated with longer survival in advanced gastric cancer.

  2017cites this paper
• Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors

  2017cites this paper
• MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.

  2017cites this paper
• Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells

  2016cites this paper
• The important application of thioridazine in the endometrial cancer.

  2016cites this paper
• The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancer

  2016influential citation
• Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy

  2016cites this paper
• Role of AKT2 in Cell Survival, Establishment and/or Maintenance of Colorectal Cancer Metastasis

  2016cites this paper
• Molecular diagnosis and molecular profiling to detect treatment-resistant ovarian cancer

  2016cites this paper
• Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells.

  2016cites this paper
• Downregulation of DNA-PKcs suppresses P-gp expression via inhibition of the Akt/NF-κB pathway in CD133-positive osteosarcoma MG-63 cells.

  2016cites this paper
• Chemoresistance and targeted therapies in ovarian and endometrial cancers

  2016influential citation
• Reversal of cisplatin resistance by inhibiting PI3K/Akt signal pathway in human lung cancer cells.

  2016cites this paper
• Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells

  2016cites this paper
• Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma

  2016cites this paper
• Inhibition of AKT sensitizes chemoresistant ovarian cancer cells to cisplatin by abrogating S and G2/M arrest.

  2016cites this paper
• Analysing Molecular Mechanism Related to Therapy- Resistance in In-vitro Models of Ovarian Cancer

  2016cites this paper
• COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization

  2015cites this paper
• MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway.

  2015cites this paper
• Gynecology & Clinical Practices

  2015cites this paper
• Molecular Mechanisms of Therapeutic Resistance in Cancer.

  2015cites this paper
• miR-23a and miR-27a Promote Human Granulosa Cell Apoptosis by Targeting SMAD51

  2015cites this paper
• Modulating effect of the PI 3-kinase inhibitor LY 294002 on cisplatin in human pancreatic cancer cells

  2015cites this paper
• Identification of potential targets for ovarian cancer treatment by systematic bioinformatics analysis.

  2015cites this paper
• N-acetylcysteine versus progesterone on the cisplatin-induced peripheral neurotoxicity.

  2015influential citation
• Doxorubicin‐Anchored Curcumin Nanoparticles for Multimode Cancer Treatment against Human Liver Carcinoma Cells

  2015cites this paper
• The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes

  2015cites this paper
• Akt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability

  2015cites this paper
• Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways.

  2015cites this paper
• DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2

  2015cites this paper
• Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes

  2015cites this paper
• Caspase-3 feedback loop enhances Bid-induced AIF/endoG and Bak activation in Bax and p53-independent manner

  2015cites this paper
• RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis

  2015cites this paper
• Platinum-resistance and AKT Over-expression in Ovarian Cancer

  2015cites this paper
• Anti‐apoptotic brain and reproductive organ‐expressed proteins enhance cisplatin resistance in lung cancer cells via the protein kinase B signaling pathway

  2015cites this paper